Ardelyx wins long battle for FDA approval of kidney-disease treatment By: MarketWatch October 17, 2023 at 19:24 PM EDT Drug previously rejected by regulators gets green light and is set to launch later this year Read More >> Related Stocks: Ardelyx, Inc. - Common Stock
